TranS1 Reports Operating Results for the First Quarter of 2012, Issues Second Quarter 2012 Guidance

Published: May 09, 2012

WILMINGTON, N.C., May 8, 2012 (GLOBE NEWSWIRE) -- TranS1 Inc. (Nasdaq:TSON), a medical device company focused on designing, developing and marketing products to treat degenerative conditions of the spine affecting the lower lumbar region, today announced its financial results for the first quarter ended March 31, 2012.

Back to news